Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine

Kidney International

Volumn 75, Issue 3, 2009, Pages 327-332

  Cherney, David Z I ^a   Scholey, James W ^a   Zhou, Joyce ^a   Zimpelmann, Joseph ^b   Kennedy, Christopher ^b   Burns, Kevin D ^b   Lai, Vesta ^a   Miller, Judith A ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Effective renal plasma flow; Endothelial nitric oxide synthase; Functional gene polymorphism; Glomerular filtration rate; Nitric oxide; Renal hemodynamic function

Indexed keywords

ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INTAKE;

ADOLESCENT; ADULT; ALLELES; ARGININE; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RENAL CIRCULATION; YOUNG ADULT;

EID: 58349121465     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.574     Document Type: Article

References (53)

1. Colombo MG, Paradossi U, Andreassi MG et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 2003; 49: 389-395.
2. Erbs S, Mobius-Winkler S, Linke A et al. Both T-786C and G894T polymorphism of endothelial nitric oxide synthase affect in-vitro endothelium-dependent relaxation of internal mammary artery rings from patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2006; 13: 826-831.
3. Kim IJ, Bae J, Lim SW et al. Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res 2007; 119: 579-585.
4. Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567-2578.
5. Fairchild TA, Fulton D, Fontana JT et al. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)->Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 2001; 276: 26674-26679.
6. Rudic RD, Shesely EG, Maeda N et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998; 101: 731-736.
7. Shin Shin Y, Baek SH, Chang KY et al. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 2004; 65: 257-265.
8. Colombo MG, Andreassi MG, Paradossi U et al. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298->Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 2002; 87: 525-528.
9. Lapu-Bula R, Quarshie A, Lyn D et al. The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. J Natl Med Assoc 2005; 97: 197-205.
10. Miyamoto Y, Saito Y, Kajiyama N et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8.
11. Page A, Reich H, Zhou J et al. Endothelial nitric oxide synthase gene/ gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol 2005; 16: 3053-3060.
12. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
13. Haynes WG, Noon JP, Walker BR et al. L-NMMA increases blood pressure in man. Lancet 1993; 342: 931-932.
14. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990; 30: 535-560.
15. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 1995; 268(5 Pt 2): F885-F898.
16. Patzak A, Persson AE. Angiotensin II-nitric oxide interaction in the kidney. Curr Opin Nephrol Hypertens 2007; 16: 46-51.
17. Klahr S, Morrissey J. L-arginine as a therapeutic tool in kidney disease. Semin Nephrol 2004; 24: 389-394.
18. Biggi A, Carra N, Cabassi A et al. Impaired renal haemodynamic response to L-arginine in essential hypertension: role of buffering anion and tubuloglomerular feedback. J Hypertens 2007; 25: 679-688.
19. Schlaich MP, Jacobi J, John S et al. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature? Clin Sci (Lond) 2000; 99: 293-302.
20. Koller-Strametz J, Wolzt M, Fuchs C et al. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients. Kidney Int 1999; 55: 1871-1877.
21. Antoniades C, Tousoulis D, Vasiliadou C et al. Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol 2005; 46: 1101-1109.
22. Dosenko VE, Zagoriy VY, Haytovich NV et al. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim Pol 2006; 53: 299-302.
23. Tesauro M, Thompson WC, Rogliani P et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832-2835.
24. Philip I, Plantefeve G, Vuillaumier-Barrot S et al. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999; 99: 3096-3098.
25. Wattanapitayakul SK, Mihm MJ, Young AP et al. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 2001; 22: 361-368.
26. Antoniades C, Tousoulis D, Vasiliadou C et al. Genetic polymorphisms G894T on the eNOS gene is associated with endothelial function and vWF levels in premature myocardial infarction survivors. Int J Cardiol 2006; 107: 95-100.
27. Testa A, Spoto B, Tripepi G et al. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. J Hypertens 2005; 23: 1825-1830.
28. Gabbai FB. Effects of nitric oxide synthase blockers on renal function. Nephrol Dial Transplant 2001; 16(Suppl 1): 10-13.
29. Sampaio MF, Hirata MH, Hirata RD et al. AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. Clin Chim Acta 2007; 377: 154-162.
30. Metzger IF, Sertorio JT, Tanus-Santos JE. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol (Oxf) 2006; 188: 123-127.
31. Feil R, Kemp-Harper B. cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications. EMBO Rep 2006; 7: 149-153.
32. Arnal JF, Warin L, Michel JB. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992; 90: 647-652.
33. Cherney DZ, Scholey JW, Cattran DC et al. The effect of oral contraceptives on the nitric oxide system and renal function. Am J Physiol Renal Physiol 2007; 293: F1539-F1544.
34. Tolins JP, Raij L. Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor. Hypertension 1991; 17(6 Pt 2): 1045-1051.
35. Shultz PJ, Schorer AE, Raij L. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 1990; 258(1 Pt 2): F162-F167.
36. De Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat. J Clin Invest 1992; 89: 1248-1256.
37. Hennington BS, Zhang H, Miller MT et al. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 1998; 31(1 Pt 2): 283-288.
38. Ohishi K, Carmines PK, Inscho EW et al. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am J Physiol 1992; 263(5 Pt 2): F900-F906.
39. Granger JP, Kassab S, Novak J et al. Role of nitric oxide in modulating renal function and arterial pressure during chronic aldosterone excess. Am J Physiol 1999; 276(1 Pt 2): R197-R202.
40. Riazi S, Khan O, Hu X et al. Aldosterone infusion with high-NaCl diet increases blood pressure in obese but not lean Zucker rats. Am J Physiol Renal Physiol 2006; 291: F597-F605.
41. Hollenberg NK. Intrarenal and systemic actions of the renin-angiotensin system. Implications for renal excretory function and sodium homeostasis. Contrib Nephrol 1984; 43: 102-113.
42. Miller JA, Curtis JR, Sochett EB. Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes. Diabetes 2003; 52: 1806-1811.
43. Miller JA, Floras JS, Skorecki KL et al. Renal and humoral responses to sustained cardiopulmonary baroreceptor deactivation in humans. Am J Physiol 1991; 260(3 Pt 2): R642-R648.
44. Miller JA, Floras JS, Zinman B et al. Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am J Physiol 1994; 266(2 Pt 2): R442-R450.
45. Miller JA, Floras JS, Zinman B et al. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond) 1996; 90: 189-195.
46. Miller JA, Scholey JW, Thai K et al. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. Kidney Int 1997; 51: 119-124.
47. Miller JA, Thai K, Scholey JW. Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes 2000; 49: 1585-1589.
48. Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005; 68: 1722-1728.
49. Chidambaram M, Duncan JA, Lai VS et al. Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 2002; 13: 446-452.
50. Kang AK, Duncan JA, Cattran DC et al. Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol 2001; 280: R807-R813.
51. Simon D, Hartmann DJ, Badouaille G et al. Two-site direct immunoassay specific for active renin. Clin Chem 1992; 38: 1959-1962.
52. Umemura S, Nyui N, Tamura K et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10: 629-633.
53. Miller JA, Cherney DZ, Duncan JA et al. Gender differences in the renal response to Renin-Angiotensin system blockade. J Am Soc Nephrol 2006; 17: 2554-2560.